The U.S. Food and Drug Administration recently approved a blood test that the U.S. Army Medical Materiel Development Activity at Fort Detrick worked on with Abbott Point of Care, which can more ...
- The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ ...
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, ...
The test, run on Abbott (ABT)'s portable i-STAT ® Alinity ® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury. The Food and Drug ...
The i-STAT TBI blood test is transforming traumatic brain injury (TBI) assessment, especially for sports-related concussions. The test, developed by Abbott along with the U.S. Department of Defense, ...
The US Food and Drug Administration (FDA) has approved the first rapid handheld blood test for suspected mild traumatic brain injury (TBI), the company has announced. The test yields results within 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback